Advances in opioid antagonist treatment for opioid addiction.
Type
Journal articleSubject
HumansOpioid-Related Disorders
Naltrexone
Adrenergic alpha-Agonists
GABA Agonists
Narcotic Antagonists
Antidepressive Agents
Delayed-Action Preparations
Treatment Outcome
Drug Therapy, Combination
Injections, Intramuscular
Behavior Therapy
Randomized Controlled Trials as Topic
Medication Adherence
Secondary Prevention
Permalink
https://hdl.handle.net/10161/19962Published Version (Please cite this version)
10.1016/j.psc.2012.03.002Publication Info
(2012). Advances in opioid antagonist treatment for opioid addiction. The Psychiatric clinics of North America, 35(2). pp. 297-308. 10.1016/j.psc.2012.03.002. Retrieved from https://hdl.handle.net/10161/19962.This is constructed from limited available data and may be imprecise. To cite this
article, please review & use the official citation provided by the journal.
Collections
More Info
Show full item recordScholars@Duke
Li-Tzy Wu
Professor in Psychiatry and Behavioral Sciences
Education/Training: Pre- and post-doctoral training in mental health service research,
psychiatric epidemiology (NIMH T32), and addiction epidemiology (NIDA T32) from Johns
Hopkins University School of Public Health (Maryland); Fellow of the NIH Summer Institute
on the Design and Conduct of Randomized Clinical Trials.Director: Duke Community Based
Substance Use Disorder Research Program.Research interests: COVID-19, Opioid misuse,
Opioid overdose, Opioid use disorder
Articles written by Duke faculty are made available through the campus open access policy. For more information see: Duke Open Access Policy
Rights for Collection: Scholarly Articles
Works are deposited here by their authors, and represent their research and opinions, not that of Duke University. Some materials and descriptions may include offensive content. More info